Evaluating Latest Evidence and Treatment Targets in Moderate to Severe Atopic Dermatitis : Episode 2

Opinion

Video

July 15, 2024

Atopic dermatitis Clinical Trial Endpoints

Author(s):

Christopher G. Bunick, MD, PhD

An atopic dermatitis expert discusses the primary and secondary efficacy endpoints and treatment goals commonly assessed in clinical trials for moderate to severe atopic dermatitis.

EP: 1.Systemic Treatments in Atopic Dermatitis: Use and Treatment Inertia

EP: 2.Atopic dermatitis Clinical Trial Endpoints

EP: 3.Treatment and Patient Reported Outcomes in Atopic Dermatitis

EP: 4.Head-to-head Study of Upadacitnib and Dupilumab in Atopic Dermatitis (Level Up)

EP: 5.Ongoing Studies in Atopic Dermatitis and Recommendations for Clinicians

Please share primary and secondary efficacy outcomes/treatment targets routinely examined in atopic dermatitis clinical trials for moderate to severe atopic dermatitis.
Is there consensus amongst experts on treatment targets?

Related Videos

Sobia Laique, MD | Credit: Cleveland Clinic

What is the Global Lung Function Initiative and Its Purpose for Lung Function Testing?

Greg A. Sachs, MD I Credit: Regenstrief Institute

3 experts are featured in this series.

Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.